Pharmaceuticals - Community Register

  

Community register of veterinary medicinal products


AUTHORISED  

Product information

Invented name: Emdocam   
Auth. number : EU/2/11/128
INN : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - Meloxicam
(See WHO ATCvet Index)
Indication: Cattle:respiratory infection, diarrhoea, acute mastitis. Pigs:in non-infectious locomotor disorders, puerperal septicaemia and toxaemia. Horses: inflammation and relief of musculo-skeletal disorders and for equine colic.
Marketing Authorisation Holder: Emdoka bvba
J. Lijsenstraat 16, B-2321 Hoogstraten, België

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/08/2011 Centralised - Authorisation EMEA/V/C/2283 (2011)6047 of 18/08/2011
11/01/2012 Centralised - Variation EMEA/V/C/2283/IB/1
Updated with Decision(2012)4178 of 14/06/2012
18/06/2012 Centralised - Variation (2012)4178 of 14/06/2012
20/12/2012 Centralised - Variation EMEA/V/C/2283/IB/3/G
Updated with Decision(2013)8829 of 03/12/2013
26/03/2013 Centralised - Variation EMEA/V/C/2283/IB/4
Updated with Decision(2013)8829 of 03/12/2013
06/12/2013 Centralised - Variation (2013)8829 of 03/12/2013
11/04/2014 Centralised - Variation EMEA/V/C/2283/IA/5